Redeye remains optimistic on the case, as we foresee a turn-around in 2021 and further progress in the years ahead. We believe Image Systems will now return to its growth path after last year’s dip. Fixed costs have been reduced significantly, while excellent gross margins and higher volumes will yield good leverage.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/